http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6c0b55b0c71dd688bd11e3b6f260b3c1
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | Molina |
| name | Arturo Molina |
| given-name | Arturo |
| organization-name | From the Division of Hematology and Hematopoietic Cell Transplantation, City of Hope Cancer Center, Duarte, CA Janssen Research & Development, Menlo Park, CA OrthoBiotech Oncology Research and Development, A Unit of Cougar Biotechnology and Institute of Urologic Oncology, David Geffen School of Medicine at University of California-Los Angeles (AB), Los Angeles, California Global Medical Affairs, Biogen Idec Inc., San Diego, CA 9Janssen Research and Development, Menlo Park, California. Cougar Biotechnology, Los Angeles, California 90024; Glenn Heller, Martin Fleisher, and Howard I. Scher, Memorial Sloan Kettering Cancer Center; Howard I. Scher, Weill Cornell Medical College, New York, NY; Robert McCormack, Janssen Research & Development, Raritan, NJ; Thian Kheoh and Arturo Molina, Janssen Research & Development, Los Angeles; Dana T. Aftab, Exelixis, South San Francisco; Mohammad Hirmand, Medivation, San Francisco, CA; Matthew R. Smith, Massachusetts General Hospital, Boston; Ana Limon, Takeda Oncology, Cambridge, MA; Robert Dreicer,... From the City of Hope Hematologic Neoplasia Program, City of Hope Cancer Center, Division of Hematology and Hematopoietic Stem Cell Transplantation, Duarte, CA. From the Urologic Oncology Program, University of California, San Francisco; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco; Cougar Biotechnology, Los Angeles, CA; Massachusetts General Hospital; Dana-Farber Cancer Institute, Lank Center for Genitourinary Oncology, Boston, MA; and Institute of Cancer Research, Drug Metabolism and Pharmacokinetics Team, Belmont, Sutton, United Kingdom. From the Roswell Park Cancer Institute, Buffalo, NY; University of California, Los Angeles; Biogen Idec, San Diego, CA; Mayo Clinic, Rochester, MN; and Northwestern University, Chicago, IL From the Division of Hematology/Oncology, Northwestern University, Feinberg School of Medicine, and the Robert H. Lurie Comprehensive Cancer Center, Chicago, IL; IDEC Pharmaceuticals, San Diego, CA; Mayo Clinic and Mayo Foundation, Rochester, MN; University of California, Los Angeles, CA; City of Hope Cancer Center, Duarte, CA; and Fox Chase Cancer Center, Philadelphia, PA Department of Oncology, Janssen Research & Development, Los Angeles, California Janssen Research & Development LLC Raritan NJ USA Division of Hematology and Bone Marrow Transplantation, and Department of Virology, City of Hope National Medical Center, Duarte, CA 91010. Authors' Affiliations: 1Janssen Research & Development, Spring House, Pennsylvania; 2Janssen Research & Development, Los Angeles, California; and 3Janssen Global Services, Raritan, New Jersey From the Divisions of Hematology and Bone Marrow Transplantation, Pediatric Oncology, Biostatistics, and Pathology, City of Hope National Medical Center, Duarte, CA. From the Division of Hematology and Bone Marrow Transplantation, Division of Pediatrics (Virology and Infectious Disease, Bone Marrow Transplantation); City of Hope Medical Center, Duarte, California; The City of Hope–Southern California Kaiser Permanente Bone Marrow Transplant Program. Sutro Biopharma San Francisco CA USA From the Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, Sutton, Surrey, United Kingdom; Genitourinary Oncology Service, Department of Medicine, Sidney Kimmel Center for Prostate and Urologic Cancers, Memorial Sloan-Kettering Cancer Center, New York, NY; University of Twente, Department of Medical Cell BioPhysics, Enschede, the Netherlands; and Cougar Biotechnology, Los Angeles; and Department of Medicine, University of California, San Francisco, CA. Howard I. Scher, Glenn Heller, Daniel C. Danila, and Martin Fleisher, Memorial Sloan Kettering Cancer Center; Howard I. Scher and Daniel C. Danila, Weill Cornell Medical College; Xiaoyu Jia, Columbia University, New York, NY; Arturo Molina, Janssen Research & Development, Menlo Park; Weimin Peng, Janssen Research & Development, Los Angeles; Thian Kheoh, Janssen Research & Development, San Diego, CA; Gerhardt Attard, Shahneen K. Sandhu, David Olmos, Ruth Riisnaes, and Johann S. de Bono, Institute of... From the Division of Hematology and Hematopoietic Cell Transplantation, Division of Information Services, Department of Radioimmunotherapy, and Division of Diagnostic Radiology, City of Hope National Medical Center, Duarte, CA; and Biogen Idec, Cambridge, MA/San Diego, CA. Clinical Development, Sutro Biopharma, South San Francisco, CA 94080, USA Graduate School of Engineering, Tecnologico de Monterrey, Campus Ciudad de Mexico; 14380 Mexico City Mexico Authors' Affiliations: 1Genitourinary Medical Oncology Program, UCSF Helen Diller Family Comprehensive Cancer Center, University of California-San Francisco, San Francisco, California; 2MD Anderson Cancer Center, Houston, Texas; 3Division of Hematology-Oncology, Massachusetts General Hospital; 4Dana-Farber Cancer Institute; 5Beth Israel Deaconess Medical Center, Boston, Massachusetts; and 6Ortho Biotech Oncology Research and Development, a Unit of Cougar Biotechnology, Los Angeles, California Sutro Biopharma, Inc., South San Francisco, California, USA From the Royal Marsden National Health Service Foundation Trust; The Institute of Cancer Research, Sutton, Surrey, United Kingdom; and Cougar Biotechnology, Los Angeles, CA. From the Divisions of Hematology/Hematopoietic Cell Transplantation and Anatomic Pathology (Hematopathology and Cytogenetics), City of Hope National Medical Center, Duarte, CA From the Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University, Chicago, IL; Division of Hematology and Diagnostic Radiology, Mayo Clinic, Rochester, MN; Department of Imaging Physics, The University of Texas M. D. Anderson Cancer Center, Houston, TX; and Medical Research, Biogen Idec, San Diego, CA. 5Janssen Research and Development, Menlo Park, California. From the National Cancer Institute, Bethesda, MD; M.D. Anderson Cancer Center, Houston, TX; Center for International Blood and Marrow Transplant Research; National Marrow Donor Program; University of Minnesota, Minneapolis, MN; University of Nebraska Medical Center, Omaha, NE; City of Hope National Cancer Center, Duarte, CA; Ohio State University, Columbus, OH; Karolinska University Hospital, Huddinge, Sweden; Mayo Clinic, Jacksonville; Massachusetts General Hospital, Boston, MA; Washington University... Divisions of Hematology and Bone Marrow Transplantation, Pediatric Oncology, Biostatistics and Pathology, City of Hope National Medical Center, Duarte, CA. Biogen Idec Inc, San Diego, CA Biogen Idec, San Diego, CA Eleni Efstathiou, Dimitra Tsavachidou, Vassiliki Tzelepi, Sijin Wen, Anh Hoang, Lisa A. Smith, Maria Karlou, Patricia Troncoso, and Christopher J. Logothetis, The University of Texas MD Anderson Cancer Center, Houston, TX; Eleni Efstathiou, University of Athens, Athens, Greece; Mark Titus, Roswell Park Cancer Institute, Buffalo, NY; and Arturo Molina and Nicole Chieffo, Ortho Biotech Oncology Research & Development (Unit of Cougar Biotechnology), Los Angeles, CA. Charles J. Ryan and Eric J. Small, University of California, San Francisco, San Francisco; Arturo Molina, Thian Kheoh, and Christopher M. Haqq, Janssen Research and Development, Los Angeles, CA; Jinhui Li, Janssen Research and Development, Raritan, NJ; Russell P. Grant, Laboratory Corporation of America, Burlington, NC; Howard I. Scher, Memorial Sloan-Kettering Cancer Center and Weill Cornell Medical College, New York, NY; Johann S. de Bono, Institute of Cancer Research and Royal Marsden Hospital, Sutton... Glenn Heller, Memorial Sloan Kettering Cancer Center, New York, NY; Robert McCormack and Thian Kheoh, Janssen Research & Development, Raritan, NJ; Arturo Molina, Janssen Research & Development, Los Angeles, CA; Matthew R. Smith, Massachusetts General Hospital, Boston, MA; Robert Dreicer, University of Virginia Medical School, Charlottesville, VA; Fred Saad, University of Montreal, Montreal, Quebec, Canada; Ronald de Wit, Erasmus Medical Center, Rotterdam, Netherlands; Dana T. Aftab, Exelixis, South San... From the Department of Medicine, Joan and Sanford E. Weill College of Medicine of Cornell University, Ithaca; Clinical Laboratories, Department of Radiology, and Sidney Kimmel Center for Prostate and Urologic Cancers, Memorial Sloan-Kettering Cancer Center, New York, NY; Cancer Research United Kingdom Centre for Cancer Therapeutics, Institute of Cancer Research, Royal Marsden Hospital, London, United Kingdom; University of California-San Francisco Comprehensive Cancer Center, San Francisco; Department of... IDEC Pharmaceuticals Corporation, 3030 Callan Road, San Diego, California 92121; Mary-Ellen Taplin, Massimo Loda, Rosina T. Lis, Wanling Xie, Zhenyang Jiang, and Philip W. Kantoff, Dana-Farber Cancer Institute, Harvard Medical School; Glenn J. Bubley, Huihui Ye, and Steven P. Balk, Beth Israel Deaconess Medical Center; Jerome P. Richie, Massimo Loda, and Rosina T. Lis, Brigham and Women's Hospital, Boston, MA; Bruce Montgomery, Bruce L. Dalkin, Lawrence D. True, and Alvin M. Matsumoto, University of Washington; Brett T. Marck and Alvin M. Matsumoto, Geriatric Research, Education and... From the City of Hope National Medical Center, Duarte, CA. Michael J. Morris, Steven M. Larson, and Howard I. Scher, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY; Arturo Molina, Thian Kheoh, Shannon L. Matheny, Vahid Naini, and Thomas W. Griffin, Janssen Research & Development, Los Angeles; Eric J. Small and Charles J. Ryan, Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA; Johann S. de Bono, Institute for Cancer Research and Royal Marsden Hospital, Sutton, United... From the Duke University Medical Center, Durham, NC; University of Texas Anderson Cancer Center, Houston, and University of Texas Health Sciences Center at San Antonio, San Antonio, TX; Hollings Cancer Center, Charleston, SC; Stanford University, Stanford, University of California Los Angeles, Los Angeles, and City of Hope, Duarte, CA; Washington University, St Louis, MO; Allegheny University, Philadelphia, and University of Pittsburgh, Pittsburgh, PA; University Hospital of Cleveland, Cleveland, OH;... 5Janssen Research & Development, Menlo Park, California. Departments of Oncology Cell Signaling and Tumor Biology, Biogen Idec, San Diego, CA; and Janssen Research and Development, Los Angeles, CA From the Division of Hematology and Hematopoietic Cell Transplantation, City of Hope Comprehensive Cancer Center, Duarte; Oncology Research and Development, Biogen Idec, San Diego, CA; and Section of Hematology and Stem Cell Transplantation, Rush University Medical Center, Chicago, IL From the Department of Hematology and Bone Marrow Transplantation, City of Hope National Medical Center, Duarte, CA; and the Bone Marrow Transplant Program, Stanford University Medical Center, Stanford, CA 3Sutro Biopharma, South San Francisco, CA 7Biogen Idec, Inc., San Diego, California 6Cougar Biotechnology, Los Angeles, California Janssen Research & Development, Menlo Park, CA, USA. |
Incoming Links
Total number of triples: 167.